Verrica Pharmaceuticals Inc. (VRCA): Price and Financial Metrics
VRCA Price/Volume Stats
Current price | $0.60 | 52-week high | $8.98 |
Prev. close | $0.59 | 52-week low | $0.38 |
Day low | $0.57 | Volume | 136,300 |
Day high | $0.62 | Avg. volume | 346,854 |
50-day MA | $0.54 | Dividend yield | N/A |
200-day MA | $0.87 | Market Cap | 55.31M |
VRCA Stock Price Chart Interactive Chart >
Verrica Pharmaceuticals Inc. (VRCA) Company Bio
Verrica Pharmaceuticals Inc. develops and commercializes dermatological treatments in the United States. The company is advancing its lead product VP-102, a proprietary topical therapy, in various common skin indications, including Molluscum contagiosum and Verruca Vulgaris. It is also developing 2 Phase 3 trials in molluscum contagiosum under NCT03377803 and NCT03377790. The company is based in West Chester, Pennsylvania.
VRCA Price Returns
1-mo | N/A |
3-mo | 37.14% |
6-mo | -12.32% |
1-year | -91.48% |
3-year | -71.56% |
5-year | -95.77% |
YTD | -14.29% |
2024 | -90.44% |
2023 | 166.18% |
2022 | -69.98% |
2021 | -20.42% |
2020 | -27.56% |
Loading social stream, please wait...